NFE2L2 and neoplasm: Given the potential significance of Nrf2 as a key target to enhance the efficacy of CAR-T cell immunotherapy, our investigation focused on exploring the distribution of TI MDSCs contributing to the composition of the ROS-rich TME in tumor-bearing NOG and NSG mice, commonly employed for xenotransplantation.60